Jonathon Golas

527 total citations
12 papers, 262 citations indexed

About

Jonathon Golas is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jonathon Golas has authored 12 papers receiving a total of 262 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Molecular Biology and 4 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jonathon Golas's work include Monoclonal and Polyclonal Antibodies Research (4 papers), Cancer Cells and Metastasis (4 papers) and Epigenetics and DNA Methylation (3 papers). Jonathon Golas is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (4 papers), Cancer Cells and Metastasis (4 papers) and Epigenetics and DNA Methylation (3 papers). Jonathon Golas collaborates with scholars based in United States and Australia. Jonathon Golas's co-authors include Kenneth G. Geles, Andreas Giannakou, Marc Damelin, Wenyan Zhong, Stephen G. Dann, Christine Loreth, Anke Klippel, Judy Lucas, Maximillian T. Follettie and Robert A. Rollins and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The EMBO Journal and Cancer Research.

In The Last Decade

Jonathon Golas

11 papers receiving 257 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathon Golas United States 7 141 127 57 44 29 12 262
Е. В. Кайгородова Russia 11 122 0.9× 189 1.5× 87 1.5× 11 0.3× 46 1.6× 41 333
Heidi M. Haikala Finland 7 212 1.5× 131 1.0× 64 1.1× 39 0.9× 24 0.8× 15 309
Christine Hosselet United States 5 108 0.8× 160 1.3× 31 0.5× 129 2.9× 12 0.4× 6 258
Yunshi Zhong China 11 219 1.6× 99 0.8× 152 2.7× 13 0.3× 20 0.7× 24 331
Chan Joo Yeom Japan 8 171 1.2× 62 0.5× 157 2.8× 17 0.4× 27 0.9× 9 290
Rhonda Walters United States 7 110 0.8× 207 1.6× 37 0.6× 21 0.5× 55 1.9× 7 352
Anna Tyutyunnykova Ukraine 3 198 1.4× 180 1.4× 122 2.1× 8 0.2× 35 1.2× 4 336
Yiyi Ji China 7 166 1.2× 85 0.7× 105 1.8× 27 0.6× 51 1.8× 13 309
Ziqi Jia China 10 87 0.6× 88 0.7× 60 1.1× 25 0.6× 14 0.5× 36 230
Yingzhuo Xu China 9 162 1.1× 121 1.0× 67 1.2× 17 0.4× 80 2.8× 9 287

Countries citing papers authored by Jonathon Golas

Since Specialization
Citations

This map shows the geographic impact of Jonathon Golas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathon Golas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathon Golas more than expected).

Fields of papers citing papers by Jonathon Golas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathon Golas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathon Golas. The network helps show where Jonathon Golas may publish in the future.

Co-authorship network of co-authors of Jonathon Golas

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathon Golas. A scholar is included among the top collaborators of Jonathon Golas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathon Golas. Jonathon Golas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Mohrs, Katja, Jonathon Golas, Timothy L. Helms, et al.. (2026). Optimally engineered HLA/peptide-specific CAR-T cells outperform TCR-T cells to eradicate solid tumors. Science Advances. 12(4). eadx9371–eadx9371.
2.
Hooper, Andrea T., et al.. (2022). Evaluation of EDB Fibronectin in Plasma, Patient-Derived Xenograft Formalin-Fixed Paraffin-Embedded and Fresh Frozen Tumor Tissues Using Immunoaffinity LC-MS/MS. Journal of Proteome Research. 21(10). 2331–2340. 5 indexed citations
3.
Giannakou, Andreas, et al.. (2020). Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression. Journal of Visualized Experiments. 7 indexed citations
4.
Giannakou, Andreas, et al.. (2020). Multidimensional Coculture System to Model Lung Squamous Carcinoma Progression. Journal of Visualized Experiments. 3 indexed citations
5.
Sung, Matthew, Erik Upeslacis, Jonathon Golas, et al.. (2018). Abstract 818: NG-HER2 ADC (PF-06804103) is superior to trastuzumab emtansine in a mouse 'avatar' head-to-head clinical trial. Cancer Research. 78(13_Supplement). 818–818. 6 indexed citations
6.
Giannakou, Andreas, Jonathon Golas, Wenyan Zhong, et al.. (2018). Cancer-associated fibroblasts suppress SOX2-induced dysplasia in a lung squamous cancer coculture. Proceedings of the National Academy of Sciences. 115(50). E11671–E11680. 54 indexed citations
7.
Sung, Matthew, Xingzhi Tan, Christine Hosselet, et al.. (2016). Abstract 2113: Caveolae-mediated endocytosis as a novel mechanism of resistance to T-DM1 ADC. Cancer Research. 76(14_Supplement). 2113–2113. 3 indexed citations
8.
Dann, Stephen G., Anthony M. Barsotti, Jonathon Golas, et al.. (2015). Reciprocal regulation of amino acid import and epigenetic state through Lat1 and EZH 2. The EMBO Journal. 34(13). 1773–1785. 49 indexed citations
9.
Barsotti, Anthony M., Wenyan Zhong, Weiguo Zhang, et al.. (2015). Epigenetic reprogramming by tumor-derived EZH2 gain-of-function mutations promotes aggressive 3D cell morphologies and enhances melanoma tumor growth. Oncotarget. 6(5). 2928–2938. 34 indexed citations
10.
Dann, Stephen G., Jonathon Golas, Miriam Miranda, et al.. (2013). p120 catenin is a key effector of a Ras-PKCɛ oncogenic signaling axis. Oncogene. 33(11). 1385–1394. 25 indexed citations
11.
Sapra, Puja, Marc Damelin, John F. DiJoseph, et al.. (2012). Long-term Tumor Regression Induced by an Antibody–Drug Conjugate That Targets 5T4, an Oncofetal Antigen Expressed on Tumor-Initiating Cells. Molecular Cancer Therapeutics. 12(1). 38–47. 51 indexed citations
12.
Hebbard, Lionel, Jonathon Golas, Junko Sawada, et al.. (2010). Control of mammary tumor differentiation by SKI-606 (bosutinib). Oncogene. 30(3). 301–312. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Е. В. Кайгородова Breakdown of academic impact, for papers by Heidi M. Haikala Breakdown of academic impact, for papers by Christine Hosselet Breakdown of academic impact, for papers by Yunshi Zhong Breakdown of academic impact, for papers by Chan Joo Yeom Breakdown of academic impact, for papers by Rhonda Walters Breakdown of academic impact, for papers by Anna Tyutyunnykova Breakdown of academic impact, for papers by Yiyi Ji Breakdown of academic impact, for papers by Ziqi Jia Breakdown of academic impact, for papers by Yingzhuo Xu
Rankless by CCL
2026